Novartis (Vaccines Business) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Novartis (Vaccines Business) General Information

Description

Provider of vaccines. The business operates as a research and development company with a technology platform based on novel adjuvants and delivery systems primarily for vaccine formulations.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Acquirer
Primary Office
  • Lichstrasse 35
  • 4056 Basel
  • Switzerland
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (Vaccines Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (Vaccines Business)‘s full profile, request access.

Request a free trial

Novartis (Vaccines Business) Executive Team (1)

Name Title Board Seat Contact Info
Jason Brown Head of Financial Planning
To view Novartis (Vaccines Business)’s complete executive team members history, request access »

Novartis (Vaccines Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (Vaccines Business)‘s full profile, request access.

Request a free trial